Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.

Friedreich ataxia (FRDA), the most common of the inherited ataxias, is an autosomal recessive degenerative disorder, characterized clinically by onset before the age of 25 of progressive gait and limb ataxia, absence of deep tendon reflexes, extensor plantar responses, and loss of position and vibration sense in the lower limbs. FRDA is caused by a GAA triplet expansion in the first intron of the FRDA gene on chromosome 9q13 in 97% of patients. The FRDA gene encodes a widely expressed 210-aa protein, frataxin, which is located in mitochondria and is severely reduced in FRDA patients. Frataxin function is still unknown but the knockout of the yeast frataxin homologue gene (YFH1) showed a severe defect of mitochondrial respiration and loss of mtDNA associated with elevated intramitochondrial iron. Here we report in vivo evidence of impaired mitochondrial respiration in skeletal muscle of FRDA patients. Using phosphorus magnetic resonance spectroscopy we demonstrated a maximum rate of muscle mitochondrial ATP production (V(max)) below the normal range in all 12 FRDA patients and a strong negative correlation between mitochondrial V(max) and the number of GAA repeats in the smaller allele. Our results show that FRDA is a nuclear-encoded mitochondrial disorder affecting oxidative phosphorylation and give a rationale for treatments aimed to improve mitochondrial function in this condition.

[1]  B CHANCE,et al.  Respiratory enzymes in oxidative phosphorylation. I. Kinetics of oxygen utilization. , 1955, The Journal of biological chemistry.

[2]  J. Durnin,et al.  Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years , 1974, British Journal of Nutrition.

[3]  H A Krebs,et al.  Cytosolic phosphorylation potential. , 1979, The Journal of biological chemistry.

[4]  P. Matthews,et al.  metabolic recovery after exercise and the assessment of mitochondrial function in Vivo in human skeletal muscle by means of 31P NMR , 1984, Magnetic resonance in medicine.

[5]  S Nioka,et al.  Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Finocchiaro,et al.  Glucose metabolism alterations in Friedreich's ataxia , 1988, Neurology.

[7]  A. Hruszkewycz.  Evidence for mitochondrial DNA damage by lipid peroxidation. , 1988, Biochemical and biophysical research communications.

[8]  Roger T. Dean,et al.  Radical initiated α-tocopherol depletion and lipid peroxidation in mitochondrial membranes , 1989 .

[9]  P. Matthews,et al.  In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondria1 disease , 1991, Neurology.

[10]  W. Bank,et al.  Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders , 1991, Annals of neurology.

[11]  G. Dobson,et al.  Substrate regulation of mitochondrial oxidative phosphorylation in hypercapnic rabbit muscle. , 1992, Journal of applied physiology.

[12]  J. Cooper,et al.  Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondrial function. , 1993, Journal of anatomy.

[13]  S. Frostick,et al.  Cellular energetics of dystrophic muscle , 1993, Journal of the Neurological Sciences.

[14]  H. Kayden.  The neurologic syndrome of vitamin E deficiency , 1993, Neurology.

[15]  G K Radda,et al.  Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle , 1993, NMR in biomedicine.

[16]  G. Radda,et al.  Bioenergetics of skeletal muscle in mitochondrial myopathy , 1994, Journal of the Neurological Sciences.

[17]  D. Johns.  Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. , 1995, The New England journal of medicine.

[18]  M. Koenig,et al.  Ataxia with isolated vitamin E deficiency is caused by mutations in the α–tocopherol transfer protein , 1995, Nature Genetics.

[19]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[20]  A Dürr,et al.  Clinical and genetic abnormalities in patients with Friedreich's ataxia. , 1996, The New England journal of medicine.

[21]  A. Munnich,et al.  Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia , 1997, Nature Genetics.

[22]  P Trouillas,et al.  Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. , 1997, Human molecular genetics.

[23]  F. Foury,et al.  Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria , 1997, FEBS letters.

[24]  Michel Koenig,et al.  Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin , 1997, Nature Genetics.

[25]  P. Zaniol,et al.  Brain and skeletal muscle bioenergetic failure in familial hypobetalipoproteinaemia. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[26]  Robert B. Wilson,et al.  Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue , 1997, Nature Genetics.

[27]  M. Pandolfo,et al.  Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.

[28]  B R Rosen,et al.  1H NMR spectroscopy studies of Huntington's disease , 1998, Neurology.

[29]  A Seller,et al.  Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy. , 1998, Brain : a journal of neurology.

[30]  R. Poland,et al.  Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats. , 1998, Archives of neurology.

[31]  D. Arnold,et al.  Intracellular phosphates in inclusion body myositis—A 31P magnetic resonance spectroscopy study , 1998 .